Cargando…

Expression of Foxp3 and interleukin-7 receptor and clinicopathological characteristics of patients with diffuse large B-cell lymphoma

The most specific biomarker on the surface of regulatory T cells (Tregs) is the forkhead/wingeded-helix protein 3 (Foxp3). In contrast, the expression of interleukin-7 receptor (IL-7R) is low or negative in Tregs. The present study aimed to investigate the expression of Foxp3 and IL-7R in diffuse la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yan, Cui, Wen-Li, Feng, Zhi-Yin, Xue, Jing, Gulinaer, Abulajiang, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068468/ https://www.ncbi.nlm.nih.gov/pubmed/32218828 http://dx.doi.org/10.3892/ol.2020.11374

Ejemplares similares

Prognostic value of MYD88 L265P mutation in diffuse large B cell lymphoma via droplet digital PCR
por: Niu, Jing, et al.
Publicado: (2020)

Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma
por: Tian, Tian, et al.
Publicado: (2020)

Clinicopathological characteristics and treatment outcome in obese patients with diffuse large B-cell lymphoma
por: Wu, Yu-Ying, et al.
Publicado: (2020)

Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics
por: Zhang, Yi-an, et al.
Publicado: (2022)

Clinicopathological analysis of polyploid diffuse large B-cell lymphoma
por: Shimono, Joji, et al.
Publicado: (2018)

The impact of FOXP3 polymorphisms on oral cancer progression and clinicopathological characteristics
por: Chen, Ping-Ju, et al.
Publicado: (2023)

Gene polymorphisms in the PI3K/AKT/mTOR signaling pathway contribute to prostate cancer susceptibility in Chinese men
por: Liu, Ting, et al.
Publicado: (2017)

Clinicopathologic Analysis of Localized Nasal/Paranasal Diffuse Large B-Cell Lymphoma
por: Toda, Hiroko, et al.
Publicado: (2013)

Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma
por: Yang, Jeong Mi, et al.
Publicado: (2018)

Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
por: Foda, Abd AlRahman Mohammad, et al.
Publicado: (2023)

Significance of ERβ expression in different molecular subtypes of breast cancer
por: Guo, Liying, et al.
Publicado: (2014)

Effect of interleukin 21 and its receptor on CD8(+) T cells in the pathogenesis of diffuse large B-cell lymphoma
por: CHA, ZHANSHAN, et al.
Publicado: (2014)

Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma
por: Zhang, Jincheng, et al.
Publicado: (2017)

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers
por: Balikó, Anett, et al.
Publicado: (2023)

Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis
por: Zhang, Ya, et al.
Publicado: (2015)

Correlation between Immunohistochemical Subtype and Clinicopathological Features in Patients with Diffuse Large B-cell Lymphoma
por: PATRASCU, ANA-MARIA, et al.
Publicado: (2017)

Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma
por: He, Huayu, et al.
Publicado: (2021)

Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy
por: Lee, Seul, et al.
Publicado: (2017)

Clinicopathological analysis of methotrexate‐associated lymphoproliferative disorders: Comparison of diffuse large B‐cell lymphoma and classical Hodgkin lymphoma types
por: Gion, Yuka, et al.
Publicado: (2017)

Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component
por: Cox, M. Christina, et al.
Publicado: (2014)

Interleukin-7 Influences FOXP3(+)CD4(+) Regulatory T Cells Peripheral Homeostasis
por: Simonetta, Federico, et al.
Publicado: (2012)

Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
por: Bai, Yuping, et al.
Publicado: (2022)

Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma
por: Lv, Xiao, et al.
Publicado: (2016)

Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma
por: Wu, Hao, et al.
Publicado: (2023)

Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma
por: Kwon, Hyun Jung, et al.
Publicado: (2018)

CD30-Positive Anaplastic Variant of Diffuse Large B-cell Lymphoma: Frequency and Association With Clinicopathological Parameters
por: Hashmi, Atif A, et al.
Publicado: (2021)

Clinicopathological spectrum of Diffuse Large B Cell lymphoma: a study targeting population yet unexplored in Pakistan
por: Mahmood, H., et al.
Publicado: (2021)

Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma
por: Lee, Ki Rim, et al.
Publicado: (2022)

Interleukin-7 Optimizes FOXP3+CD4+ Regulatory T Cells Reactivity to Interleukin-2 by Modulating CD25 Expression
por: Simonetta, Federico, et al.
Publicado: (2014)

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
por: Wong, Kah Keng, et al.
Publicado: (2016)

Endoscopic and clinicopathological characteristics of colorectal T/NK cell lymphoma
por: Ishibashi, Hideki, et al.
Publicado: (2020)

Primary Intestinal Lymphoma: Clinicopathological Characteristics of 55 Patients
por: Malipatel, Renuka, et al.
Publicado: (2021)

Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma
por: Yan, Shufang, et al.
Publicado: (2022)

Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma
por: Xing, Ai-Yan, et al.
Publicado: (2022)

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
por: Xing, Wei, et al.
Publicado: (2016)

Clinicopathological analysis of diffuse large B-cell lymphoma lacking surface immunoglobulin light chain restriction on flow cytometry
por: Nakaya, Yosuke, et al.
Publicado: (2021)

Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma
por: Nelson, Lilli S, et al.
Publicado: (2015)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified
por: Itami, Hiroe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t27ejvbo5i4e41bd4kqna7c19f